Menu Search
Equities

Dr Martens PLC

DOCSN:MEX

Dr Martens PLC

Actions
  • Price (MXN)16.88
  • Today's Change2.47 / 17.14%
  • Shares traded--
  • 1 Year change-35.35%
  • Beta--
Data delayed at least 20 minutes, as of Mar 17 2023 11:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Dr Martens PLC's revenues fell -12.32% from 1.00bn to 877.10m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 128.90m to 69.20m, a -46.31% decrease.
Gross margin65.58%
Net profit margin7.89%
Operating margin13.93%
Return on assets7.12%
Return on equity17.92%
Return on investment8.51%
More ▼

Cash flow in GBPView more

In 2024, cash reserves at Dr Martens PLC fell by 46.40m. However, the company earned 167.90m from its operations for a Cash Flow Margin of 19.14%. In addition the company used 25.50m on investing activities and also paid 185.90m in financing cash flows.
Cash flow per share0.1436
Price/Cash flow per share3.82
Book value per share0.383
Tangible book value per share0.1021
More ▼

Balance sheet in GBPView more

Dr Martens PLC has a Debt to Total Capital ratio of 56.00%, a lower figure than the previous year's 103.34%.
Current ratio2.85
Quick ratio1.19
Total debt/total equity1.27
Total debt/total capital0.56
More ▼

Growth rates in GBP

SmartText is unavailable
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)35.40%
EPS growth(5 years)32.49
EPS (TTM) vs
TTM 1 year ago		-44.99
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.